Metsera falls after accepting up to $10 billion offer from Pfizer

By Mariam Sunny (Reuters) -Shares of Metsera fell over 15% in early trading on Monday, after the weight-loss drug developer ...
BioSpace

Pfizer’s Winning Bid For Metsera Concludes ‘Real Housewives of Biopharma’

“No need for a reunion show: This seasons Real Housewives of Biopharma comes to a close with Pfizer’s winning bid for Metsera ...

Metsera (MTSR) Shares Nosedive After Pfizer Clinches Weight-Loss Biotech Deal

Metsera said it has struck a revised merger agreement with Pfizer that values the company at up to $86.25 per share in cash.

Pfizer Gets Metsera: Why The $20.65 CVR Is Highly Likely To Pay Out (In Part)

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

Pfizer's move for Metsera adds to busy year of healthcare M&A. But the sector's in a rut.

Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More

Metsera falls sharply after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 ...

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

Metsera, Inc. (NASDAQ: MTSR) today announced that it has entered into an amended merger agreement with Pfizer, pursuant to which Pfizer will acquire Metsera for up to $86.25 per share, consisting of ...